ST
SGYP

Spot Trading’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Spot Trading’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$3K Sell
1,200
-4,000
-77% -$13.6K ﹤0.01% 3006
2017
Q2 		$23K Buy
5,200
+2,500
+93% +$10.3K ﹤0.01% 2981
2017
Q1 		$13K Sell
2,700
-12,600
-82% -$73.1K ﹤0.01% 2725
2016
Q4 		$93K Buy
15,300
+300
+2% +$1.57K ﹤0.01% 2237
2016
Q3 		$83K Sell
15,000
-10,000
-40% -$46.8K ﹤0.01% 2475
2016
Q2 		$95K Buy
+25,000
New +$84.7K ﹤0.01% 2550
2015
Q3 		– Sell
-28,000
Closed -$232K – 4452
2015
Q2 		$232K Buy
28,000
+12,900
+85% +$62.5K ﹤0.01% 2619
2015
Q1 		$70K Buy
+15,100
New +$49.1K ﹤0.01% 3213
2014
Q4 		– Sell
-700
Closed -$2K – 4590
2014
Q3 		$2K Buy
+700
New +$2.54K ﹤0.01% 4217

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Spot Trading's SGYP Position: Q3 2017 in Review

Spot Trading reduced its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 4.1% in Q3 2017, selling an estimated $3.69K and leaving 25,199 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #2649.

Spot Trading first reported a position in SGYP in Q2 2014 and has held it in 6 quarters since. The position peaked at $137K in Q2 2014. 143 funds tracked by Wall St. Rank hold SGYP as of Q3 2017.

  • Spot Trading held 25,199 shares of Synergy Pharmaceuticals, Inc Common Stock worth $73K as of Q3 2017.
  • Spot Trading sold 1,082 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2017, an estimated $3.69K.
  • Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2649 holding.
  • Spot Trading first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2014 and has held it in 6 quarters since.
  • Spot Trading's Synergy Pharmaceuticals, Inc Common Stock position peaked at $137K in Q2 2014.
  • 143 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.